Suppr超能文献

外泌体 miR-1911-5p 通过 MYB/AKR1B10/ACC 调节铁死亡,以促进巨噬细胞 M2 极化介导的胃癌顺铂耐药。

Exo-miR-1911-5p regulates ferroptosis to promote macrophages M2 polarization-mediated gastric cancer cisplatin resistance via MYB/AKR1B10/ACC.

作者信息

Kong Zihao, Zhang Min, Yuan Hui, Liu Jiahao, Sang Huaiming, Zhao Ping, Xu Miao, Zhu Chuanlong, Zhang Guoxin

机构信息

Department of Gastroenterology, The First Affiliated Hospital of Nanjing Medical University, Nanjing, China.

Department of Gastroenterology, Affiliated Drum Tower Hospital of Nanjing University Medical School, Nanjing, China.

出版信息

Commun Biol. 2025 Jul 15;8(1):1054. doi: 10.1038/s42003-025-08441-w.

Abstract

Tumor-associated macrophages (TAMs) have been implicated in fostering various hallmarks of cancer progression in gastric cancer (GC). However, the intricate molecular mechanisms underlying TAM-induced chemoresistance remain incompletely understood. Exosomes emerge as key players, mediating TAM-induced resistance to cisplatin (DDP) by regulating ferroptosis. Our investigation reveals that exo-miR-1911-5p, delivered to GC cells from TAMs, significantly contributes to cisplatin resistance. Specifically, direct modulation of MYB by MiR-1911-5p leads to decreased expression of AKR1B10, a crucial factor in preventing ferroptosis. Further exploration confirms the regulation of ACC by AKR1B10. Through targeting the MYB/AKR1B10/ACC axis, exo-miR-1911-5p inhibits ferroptosis to enhances cisplatin resistance. Additionally, exo-miR-1911-5p promotes M2 polarization of TAMs by targeting ARHGEF3. Collectively, our findings highlight the critical role of exo-miR-1911-5p in mediating cisplatin resistance through modulating the cross-talk between TAMs and GC. Targeting exo-miR-1911-5p could represent a promising strategy for overcoming DDP resistance in GC.

摘要

肿瘤相关巨噬细胞(TAM)与胃癌(GC)进展的多种特征有关。然而,TAM诱导化疗耐药的复杂分子机制仍未完全了解。外泌体成为关键因素,通过调节铁死亡介导TAM诱导的顺铂(DDP)耐药。我们的研究表明,从TAM传递到GC细胞的外泌体miR-1911-5p显著导致顺铂耐药。具体而言,MiR-1911-5p对MYB的直接调节导致AKR1B10表达降低,AKR1B10是预防铁死亡的关键因素。进一步研究证实了AKR1B10对ACC的调节作用。通过靶向MYB/AKR1B10/ACC轴,外泌体miR-1911-5p抑制铁死亡以增强顺铂耐药。此外,外泌体miR-1911-5p通过靶向ARHGEF3促进TAM的M2极化。总的来说,我们的研究结果突出了外泌体miR-1911-5p在通过调节TAM与GC之间的相互作用介导顺铂耐药中的关键作用。靶向外泌体miR-1911-5p可能是克服GC中DDP耐药的一种有前景的策略。

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验